Our Story

Building the Future of Precision Therapeutics. 

Funomics was founded with a simple belief: the next generation of therapeutics will be driven by a deeper understanding of biology at the molecular level. As advances in metabolomics, microbiome science, and small-molecule chemistry transform the life sciences industry, researchers need integrated partners who can translate scientific insights into real therapies. Funomics was created to meet that need.

Based in Canada, Funomics brings together expertise in contract research (CRO) and contract development and manufacturing (CDMO) to support innovators from early discovery through clinical development and manufacturing.

Our goal is to accelerate the development of next-generation therapeutics by combining advanced analytical platforms, scientific expertise, and scalable manufacturing solutions.

The Vision

The human metabolome and microbiome hold enormous potential for transforming medicine. These complex biological systems influence disease pathways, drug response, and therapeutic outcomes.

Funomics was built to unlock this potential.

By integrating metabolomics analysis, microbiome research, and small-molecule development, we help our partners discover new biomarkers, identify therapeutic targets, and develop innovative treatments.

Our vision is to become a trusted partner for biotech and pharmaceutical innovators developing precision medicines.

Our Approach

Funomics operates at the intersection of research, development, and manufacturing.

We provide integrated services that support the full therapeutic development pipeline:

• Metabolomics and microbiome analysis for biomarker discovery

• Small-molecule drug development and optimization

• Preclinical research and analytical testing

• Process development and formulation

• GMP manufacturing for clinical programs

This end-to-end approach allows our partners to move efficiently from discovery to production with a single trusted collaborator.

Why Canada

Canada is one of the world’s fastest-growing life sciences ecosystems, supported by strong academic institutions, advanced research infrastructure, and a collaborative innovation environment.

Operating from Canada allows Funomics to work closely with universities, research hospitals, biotech companies, and global pharmaceutical partners to advance therapeutic innovation.

Our Commitment

At Funomics, we believe scientific progress should translate into real benefits for patients.

Our team is committed to:

• scientific excellence

• rigorous quality standards

• collaborative partnerships

• accelerating therapeutic innovation

By helping our partners move discoveries from the laboratory to the clinic, we aim to contribute to the development of safer, more effective therapies for patients worldwide.

Partner With Funomics

Whether you are developing a novel therapeutic, exploring metabolomics insights, or advancing a clinical program, Funomics is ready to support your journey.

Together, we can accelerate the future of precision medicine.